Global Plasmid DNA Manufacturing Market Size study & Forecast, by Grade, by Development, by Application, by Disease and Regional Analysis, 2022-2029

Description

List of Tables

Global Plasmid DNA Manufacturing Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Plasmid DNA manufacturing is a process of producing plasmid DNA that is directly used as a therapeutic agent such as in gene therapy or vaccine generation antigens. Factors such as the flourishing growth of the healthcare industry, the rising number of patients opting for gene therapy, and the increasing demand for plasmid DNA in various medical therapies are upsurging the market demand across the world.

According to Statista, in 2019, the global cancer gene therapy market was estimated to value around USD 560 million, which is anticipated to grow and is likely to reach USD 16,500 million by the year 2030. Therefore, the increasing demand for gene therapy is exhibiting a positive influence on the growth of the Plasmid DNA Manufacturing Market. In addition, a robust pipeline for gene therapies, as well as the increasing number of strategies by the key market players are offering various lucrative opportunities for market growth in the forecasting years. However, the imposition of a stringent regulatory framework and ethical challenges associated with gene therapy are hindering stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Plasmid DNA Manufacturing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the rising emphasis on the establishing Recombinant DNA Advisory Committee, along with the growing investment the R&D activities. Whereas, Asia Pacific is expected to grow significantly during the forecast period. Factors such as

rising inclination toward the development and marketing of stem cells, untapped opportunities, as well as growing incidences of target diseases are burgeoning the market growth in the forecasting years.

Major market players included in this report are:

Charles River Laboratories

VGXI, Inc.

Aldevron

Kaneka Corp.

Nature Technology

Cell and Gene Therapy Catapult

Eurofins Genomics

Lonza

Luminous BioSciences, LLC

Akron Biotech

Recent Developments in the Market:

in July 2021, Thermo Fisher announced the establishment of its current Good Manufacturing Practice (cGMP) facility in Carlsbad, California, with the objective of boosting its clinical and business capabilities for the synthesis of pDNA for cells and gene-based therapies.
In June 2021, Biotage announced the introduction of Biotage PhyPrep- a new automated solution for plasmid DNA purification. This new automated solution for plasmid DNA purification saves lab technicians' time by eradicating the requirement to perform repetitive, manual work and also helps in producing supercoiled, endotoxin-free, transfection-grade pDNA.

Global Plasmid DNA Manufacturing Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Grade, Development, Application, Disease, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Grade:

R&D Grade

GMP Grade

By Development:

Pre-Clinical Therapeutics

Clinical Therapeutics

Marketed Therapeutics

By Application:

DNA Vaccines

Cell & Gene Therapy

Immunotherapy

Others

By Disease:

Infectious Disease

Cancer

Genetic Disorder

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Plasmid DNA Manufacturing Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Plasmid DNA Manufacturing Market, by Grade, 2019-2029 (USD Billion)
- 1.2.3. Plasmid DNA Manufacturing Market, by Development, 2019-2029 (USD Billion)
- 1.2.4. Plasmid DNA Manufacturing Market, by Application, 2019-2029 (USD Billion)
- 1.2.5. Plasmid DNA Manufacturing Market, by Disease, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Plasmid DNA Manufacturing Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Plasmid DNA Manufacturing Market Dynamics

3.1. Plasmid DNA Manufacturing Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising number of patients opting for gene therapy
  - 3.1.1.2. Increasing demand for plasmid DNA in various medical therapies
- 3.1.2. Market Challenges
  - 3.1.2.1. Imposition of the stringent regulatory framework
  - 3.1.2.2. Ethical challenges associated with gene therapy
- 3.1.3. Market Opportunities
  - 3.1.3.1. Robust pipeline for gene therapies
  - 3.1.3.2. Increasing number of strategies by the key market players

Chapter 4. Global Plasmid DNA Manufacturing Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Plasmid DNA Manufacturing Market, by Grade

6.1. Market Snapshot
6.2. Global Plasmid DNA Manufacturing Market by Grade, Performance - Potential Analysis
6.3. Global Plasmid DNA Manufacturing Market Estimates & Forecasts by Grade, 2019-2029 (USD Billion)
6.4. Plasmid DNA Manufacturing Market, Sub Segment Analysis
- 6.4.1. R&D Grade
- 6.4.2. GMP Grade

Chapter 7. Global Plasmid DNA Manufacturing Market, by Development

7.1. Market Snapshot
7.2. Global Plasmid DNA Manufacturing Market by Development, Performance - Potential Analysis
7.3. Global Plasmid DNA Manufacturing Market Estimates & Forecasts by Development, 2019-2029 (USD Billion)
7.4. Plasmid DNA Manufacturing Market, Sub Segment Analysis
- 7.4.1. Pre-Clinical Therapeutics
- 7.4.2. Clinical Therapeutics
- 7.4.3. Marketed Therapeutics

Chapter 8. Global Plasmid DNA Manufacturing Market, by Application

8.1. Market Snapshot
8.2. Global Plasmid DNA Manufacturing Market by Application, Performance - Potential Analysis
8.3. Global Plasmid DNA Manufacturing Market Estimates & Forecasts by Application, 2019-2029 (USD Billion)
8.4. Plasmid DNA Manufacturing Market, Sub Segment Analysis
- 8.4.1. DNA Vaccines
- 8.4.2. Cell & Gene Therapy
- 8.4.3. Immunotherapy
- 8.4.4. Others

Chapter 9. Global Plasmid DNA Manufacturing Market, by Disease

9.1. Market Snapshot
9.2. Global Plasmid DNA Manufacturing Market by Disease, Performance - Potential Analysis
9.3. Global Plasmid DNA Manufacturing Market Estimates & Forecasts by Disease, 2019-2029 (USD Billion)
9.4. Plasmid DNA Manufacturing Market, Sub Segment Analysis
- 9.4.1. Infectious Disease
- 9.4.2. Cancer
- 9.4.3. Genetic Disorder

Chapter 10. Global Plasmid DNA Manufacturing Market, Regional Analysis

10.1. Plasmid DNA Manufacturing Market, Regional Market Snapshot
10.2. North America Plasmid DNA Manufacturing Market
- 10.2.1. U.S. Plasmid DNA Manufacturing Market
  - 10.2.1.1. Grade breakdown estimates & forecasts, 2019-2029
  - 10.2.1.2. Development breakdown estimates & forecasts, 2019-2029
  - 10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
  - 10.2.1.4. Disease breakdown estimates & forecasts, 2019-2029
- 10.2.2. Canada Plasmid DNA Manufacturing Market
10.3. Europe Plasmid DNA Manufacturing Market Snapshot
- 10.3.1. U.K. Plasmid DNA Manufacturing Market
- 10.3.2. Germany Plasmid DNA Manufacturing Market
- 10.3.3. France Plasmid DNA Manufacturing Market
- 10.3.4. Spain Plasmid DNA Manufacturing Market
- 10.3.5. Italy Plasmid DNA Manufacturing Market
- 10.3.6. Rest of Europe Plasmid DNA Manufacturing Market
10.4. Asia-Pacific Plasmid DNA Manufacturing Market Snapshot
- 10.4.1. China Plasmid DNA Manufacturing Market
- 10.4.2. India Plasmid DNA Manufacturing Market
- 10.4.3. Japan Plasmid DNA Manufacturing Market
- 10.4.4. Australia Plasmid DNA Manufacturing Market
- 10.4.5. South Korea Plasmid DNA Manufacturing Market
- 10.4.6. Rest of Asia Pacific Plasmid DNA Manufacturing Market
10.5. Latin America Plasmid DNA Manufacturing Market Snapshot
- 10.5.1. Brazil Plasmid DNA Manufacturing Market
- 10.5.2. Mexico Plasmid DNA Manufacturing Market
10.6. Rest of The World Plasmid DNA Manufacturing Market

Chapter 11. Competitive Intelligence

11.1. Top Market Strategies
11.2. Company Profiles
- 11.2.1. Charles River Laboratories
  - 11.2.1.1. Key Information
  - 11.2.1.2. Overview
  - 11.2.1.3. Financial (Subject to Data Availability)
  - 11.2.1.4. Product Summary
  - 11.2.1.5. Recent Developments
- 11.2.2. VGXI, Inc.
- 11.2.3. Aldevron
- 11.2.4. Kaneka Corp.
- 11.2.5. Nature Technology
- 11.2.6. Cell and Gene Therapy Catapult
- 11.2.7. Eurofins Genomics
- 11.2.8. Lonza
- 11.2.9. Luminous BioSciences, LLC
- 11.2.10. Akron Biotech

Chapter 12. Research Process

12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Plasmid DNA Manufacturing Market, report scope
TABLE 2. Global Plasmid DNA Manufacturing Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Plasmid DNA Manufacturing Market estimates & forecasts by Grade 2019-2029 (USD Billion)
TABLE 4. Global Plasmid DNA Manufacturing Market estimates & forecasts by Development 2019-2029 (USD Billion)
TABLE 5. Global Plasmid DNA Manufacturing Market estimates & forecasts by Application 2019-2029 (USD Billion)
TABLE 6. Global Plasmid DNA Manufacturing Market estimates & forecasts by Disease 2019-2029 (USD Billion)
TABLE 7. Global Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Plasmid DNA Manufacturing Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Plasmid DNA Manufacturing Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Plasmid DNA Manufacturing Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Plasmid DNA Manufacturing Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Plasmid DNA Manufacturing Market
TABLE 72. List of primary sources, used in the study of global Plasmid DNA Manufacturing Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Plasmid DNA Manufacturing Market, research methodology
FIG 2. Global Plasmid DNA Manufacturing Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Plasmid DNA Manufacturing Market, key trends 2021
FIG 5. Global Plasmid DNA Manufacturing Market, growth prospects 2022-2029
FIG 6. Global Plasmid DNA Manufacturing Market, porters 5 force model
FIG 7. Global Plasmid DNA Manufacturing Market, pest analysis
FIG 8. Global Plasmid DNA Manufacturing Market, value chain analysis
FIG 9. Global Plasmid DNA Manufacturing Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Plasmid DNA Manufacturing Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Plasmid DNA Manufacturing Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Plasmid DNA Manufacturing Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Plasmid DNA Manufacturing Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Plasmid DNA Manufacturing Market, regional snapshot 2019 & 2029
FIG 15. North America Plasmid DNA Manufacturing Market 2019 & 2029 (USD Billion)
FIG 16. Europe Plasmid DNA Manufacturing Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Plasmid DNA Manufacturing Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Plasmid DNA Manufacturing Market 2019 & 2029 (USD Billion)
FIG 19. Global Plasmid DNA Manufacturing Market, company Market share analysis (2021)